BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18208815)

  • 1. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    Taketa K; Matsumura T; Yano M; Ishii N; Senokuchi T; Motoshima H; Murata Y; Kim-Mitsuyama S; Kawada T; Itabe H; Takeya M; Nishikawa T; Tsuruzoe K; Araki E
    J Biol Chem; 2008 Apr; 283(15):9852-62. PubMed ID: 18208815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
    Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
    J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein activates adipophilin through ERK1/2 signal pathway in RAW264.7 cells.
    Liu Q; Dai Z; Liu Z; Liu X; Tang C; Wang Z; Yi G; Liu L; Jiang Z; Yang Y; Yuan Z
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):635-45. PubMed ID: 20710016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY; Kim HS
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
    Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E
    Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation.
    Yin R; Dong YG; Li HL
    Acta Pharmacol Sin; 2006 Sep; 27(9):1146-52. PubMed ID: 16923334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OxLDL up-regulates Niemann-Pick type C1 expression through ERK1/2/COX-2/PPARα-signaling pathway in macrophages.
    Yu X; Li X; Zhao G; Xiao J; Mo Z; Yin K; Jiang Z; Fu Y; Zha X; Tang C
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):119-28. PubMed ID: 22232299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB.
    Matsuo T; Matsumura T; Sakai M; Senokuchi T; Yano M; Kiritoshi S; Sonoda K; Kukidome D; Pestell RG; Brownlee M; Nishikawa T; Araki E
    Biochem Biophys Res Commun; 2004 Feb; 314(3):817-23. PubMed ID: 14741709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
    Pang L; Nie M; Corbett L; Knox AJ
    J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native LDL and oxidized LDL modulate cyclooxygenase-2 expression in HUVECs through a p38-MAPK, NF-kappaB, CRE dependent pathway and affect PGE2 synthesis.
    Norata GD; Pirillo A; Pellegatta F; Inoue H; Catapano AL
    Int J Mol Med; 2004 Sep; 14(3):353-9. PubMed ID: 15289885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes.
    Li H; Zhao Y; Zhou S; Heng CK
    Biochemistry; 2010 Nov; 49(44):9508-17. PubMed ID: 20853849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation.
    Ulivi V; Cancedda R; Cancedda FD
    J Cell Physiol; 2008 Nov; 217(2):433-41. PubMed ID: 18615580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes.
    Yoon EK; Lee WK; Lee JH; Yu SM; Hwang SG; Kim SJ
    J Korean Med Sci; 2007 Dec; 22(6):1015-21. PubMed ID: 18162716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
    Raman P; Kaplan BL; Thompson JT; Vanden Heuvel JP; Kaminski NE
    Mol Pharmacol; 2011 Jul; 80(1):201-9. PubMed ID: 21511917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.